Prevalence and Outcomes of Chronic Kidney Disease-Associated Pruritus
Pruritus is highly prevalent in PD and associated with poor health outcomes. Efforts to better identify and manage pruritus should be considered in this population.
Authors
- Mark Lambie (ORCID: https://orcid.org/0000-0002-6285-5368)
- Brian A. Bieber (ORCID: https://orcid.org/0000-0001-8505-0979)
- Jeffrey M. Perl (ORCID: https://orcid.org/0000-0002-0008-7623)
- Karthik Tennankore (ORCID: https://orcid.org/0000-0002-7919-6709)
- Talerngsak Kanjanabuch (ORCID: https://orcid.org/0000-0002-2996-8934)
- Yeoungjee Cho (ORCID: https://orcid.org/0000-0002-3502-9837)
- David Wayne Johnson (ORCID: https://orcid.org/0000-0001-5491-3460)
- Keith McCullough (ORCID: https://orcid.org/0000-0003-1995-1888)
- Hideki Kawanishi (ORCID: https://orcid.org/0000-0002-1207-0888)
- Jenny I. Shen (ORCID: https://orcid.org/0000-0002-2993-403X)
- Claudio Rigatto (ORCID: https://orcid.org/0000-0002-8306-8072)
- Yong-Lim Kim (ORCID: https://orcid.org/0000-0002-1344-3455)
- Martin A. Schreiber (ORCID: https://orcid.org/0000-0002-4430-6779)
- Ronald L. Pisoni
Institutions
- St. Michael's Hospital (CA)
- Dalhousie University (CA)
- Translational Research Institute (AU)
- Chulalongkorn University (TH)
- The University of Queensland (AU)
- University Hospitals of North Midlands NHS Trust (GB)
- Royal Stoke University Hospital (GB)
- UCLA Medical Center (US)
- Princess Alexandra Hospital (AU)
- Nova Scotia Health Authority (CA)
- Kyungpook National University (KR)
- Hiroshima General Hospital (JP)
- Kidney Health Australia (AU)
- Orthopaedic Innovation Centre (CA)
- Arbor Research Collaborative for Health (US)
- Colorado Kidney Care (US)
- Harbor–UCLA Medical Center (US)
- University of Manitoba (CA)
- Keele University (GB)
Publication Details
- Journal
- Clinical Journal of the American Society of Nephrology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.2215/cjn.0000000000000537
- Citations
- 12
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 6.42
Funders
- Amgen
- Astellas Pharma US
- Kissei
- Torii Pharmaceutical
- Kyowa Hakko Kirin
- Vifor Pharma
- Kidney Foundation, Japan
- Terumo
- Ono Pharmaceutical
- Cara
- Akebia Therapeutics
- National Institutes of Health
- Baxter Healthcare Corporation
- Chugai Pharmaceutical
- MSD K.K.
- Bayer Yakuhin